Literature DB >> 30584855

Uncontrolled DCD: When Should We Stop Trying to Save the Patient and Focus on Saving the Organs?

Iván Ortega-Deballon, David Rodríguez-Arias.   

Abstract

Uncontrolled donation after circulatory death, which occurs when an individual has experienced unexpected cardiac arrest, usually not in a hospital, generates both excitement and concern. On the one hand, uDCD programs have the capacity to significantly increase organ donation rates, with good transplant outcomes-mainly for kidneys, but also for livers and lungs. On the other hand, uDCD raises a number of ethical challenges. In this essay, we focus on an issue that is central to all uDCD protocols: When should we cease resuscitation and shift to organ preservation? Do current uDCD protocols prematurely consider as potential donors patients who could still have some chances of meaningful survival? Can the best interest of patients be fostered once they are considered and treated as potential donors?
© 2018 The Hastings Center.

Entities:  

Mesh:

Year:  2018        PMID: 30584855     DOI: 10.1002/hast.950

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


  3 in total

Review 1.  Ethical and legal considerations related to disorders of consciousness.

Authors:  Lauren Rissman; Erin Talati Paquette
Journal:  Curr Opin Pediatr       Date:  2020-12       Impact factor: 2.856

2.  Experience of extracorporeal cardiopulmonary resuscitation in a refractory cardiac arrest patient at the emergency department.

Authors:  Kap Su Han; Su Jin Kim; Eui Jung Lee; Jae Seung Jung; Jae Hyoung Park; Sung Woo Lee
Journal:  Clin Cardiol       Date:  2019-03-18       Impact factor: 2.882

3.  Program of Uncontrolled Donation After Circulatory Death as Potential Solution to the Shortage of Organs: A Canadian Single-Center Retrospective Cohort Study.

Authors:  Frederick D'Aragon; Olivier Lachance; Vincent Lafleur; Ivan Ortega-Deballon; Marie-Helene Masse; Gabrielle Trepanier; Daphnee Lamarche; Marie-Claude Battista
Journal:  Open Access Emerg Med       Date:  2022-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.